EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition

Shiliang Li iD, Fang Ye, Yucheng Zheng, Jie Wang, Haoran Peng, Lili Zhu, Lili Chen, Tao Yu, Huan Ge, Jiaqi He, Binghao Zhang, Jiayun Wu und 10 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202417534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Shiliang Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, Shanghai, 200062, China. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Science, Technology, and Innovation Commission of Shenzhen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS‐CoV‐2 spike (S) protein, a trimeric structure comprising three receptor binding domains (RBDs) and three N‐terminal domains (NTDs), undergoes substantial conformational changes to a fusion‐prone open state for angiotensin‐converting enzyme 2 (ACE2) binding and host cell infection. Stabilizing its closed state is a key antiviral strategy but remains challenging. Here, we introduce S416, a novel amphipathic molecule acting as a “molecular bolt”. Cryo‐EM study reveals that S416 binds concurrently to six sites across two distinct druggable interfaces: three molecules at the RBD‐RBD interfaces and three at the NTD‐RBD interfaces. This unique “dual‐locking” mechanism, driven by S416's polar carboxyl head and nonpolar phenylthiazole tail, robustly stabilizes the spike trimer in a locked, closed conformation through strong inter‐domain interactions, reducing structural flexibility and atomic fluctuations compared to the apo structure resolved synchronously. Crucially, these RBD‐RBD and NTD‐RBD interfaces are conserved across human‐infecting coronaviruses, suggesting potential as broad‐spectrum antiviral targets. Our findings demonstrate that the highly dynamic spike trimer can be effectively stabilized by an amphipathic molecular bolt targeting both the inter‐ and intra‐monomer interfaces, offering a promising strategy against emerging coronaviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Antiviral AgentsCOVID-19 Drug TreatmentHumansCryoelectron MicroscopyAngiotensin-Converting Enzyme 2COVID-19Protein BindingProtein MultimerizationProtein DomainsProtein Conformation

Stichwörter der Autor:innen

RBD‐NTD interfaceRBD‐RBD interfaceSARS‐CoV‐2amphipathic molecular boltdruggable interfacesentry inhibitorspike trimer stabilization

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antiviral AgentsAngiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Innovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, Shanghai, 200062, China.
  • Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science & Technology, Shanghai, 200237, China.
  • Department of Pain Management, HuaDong Hospital affiliated to Fudan University, Shanghai, 200040, China.
  • Kobilka Institute of Innovative Drug Discovery, School of Medicine, Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.
  • State Key Laboratory of Virology and Biosafety, Taikang Center for Life and Medical Sciences, College of Life Sciences, Wuhan University, Wuhan, Hubei, 430072, China.
  • Department of Microbiology, Navy Medical University, Shanghai, 200433, China.

ORCID-Profile: Shiliang Li, Honglin Li

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Science, Technology, and Innovation Commission of Shenzhen Municipality
  • Kobilka Institute of Innovative Drug Discovery in Shenzhen, and the Science and Technology Foundation of Hubei Province
  • Shanghai Rising-Star Program
  • National Key Research and Development Program of China

Zitieren

APA

Li, S., Ye, F., Zheng, Y., Wang, J., Peng, H., Zhu, L., Chen, L., Yu, T., Ge, H., He, J., Zhang, B., Wu, J., Zhang, Z., Jiang, L., Chen, G., Zhao, P., Lan, K., Zhao, Z., Qian, X., …, & Li, H. (2025). Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition. Advanced Science. https://doi.org/10.1002/advs.202417534

Vancouver

Li S, Ye F, Zheng Y, Wang J, Peng H, Zhu L, et al. Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition. Advanced Science. 2025. doi:10.1002/advs.202417534

BibTeX
@article{Li2025,
  author = {Li, Shiliang and Ye, Fang and Zheng, Yucheng and Wang, Jie and Peng, Haoran and Zhu, Lili and Chen, Lili and Yu, Tao and Ge, Huan and He, Jiaqi and Zhang, Binghao and Wu, Jiayun and Zhang, Zhiyi and Jiang, Liangliang and Chen, Geng and Zhao, Ping and Lan, Ke and Zhao, Zhenjiang and Qian, Xuhong and Xu, Ke and Du, Yang and Li, Honglin},
  title = {Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202417534}
}
Kostenlos starten →